Longitudinal Randomized Controlled Study on the Effectiveness of Nutritional Education During Uncomplicated Pregnancy (MaNu)

April 20, 2026 updated by: Azienda Sanitaria Locale CN2 Alba-Bra

Longitudinal, Randomized, Parallel-Group, Controlled Clinical Study to Evaluate the Effectiveness of a Nutritional Education Intervention in Uncomplicated Pregnancy

The goal of this clinical trial is to evaluate whether a structured nutritional education intervention can improve gestational weight gain outcomes and related maternal and neonatal health indicators in women with uncomplicated pregnancy. The main question it aims to answer is whether a group-based nutritional education program increases the proportion of women achieving gestational weight gain within Institute of Medicine (IOM) recommended ranges compared with standard prenatal care.

Researchers will compare a structured nutritional education intervention group to a control group receiving routine prenatal care and a nutritional information brochure to see if the intervention improves gestational weight gain within recommended ranges and affects maternal and neonatal outcomes.

Participants in the intervention group will:

  • Attend three weekly group-based nutritional education sessions delivered by trained healthcare professionals
  • Attend one practical cooking (show-cooking) session

Participants in the control group will:

  • Receive routine prenatal care and a written nutritional information brochure
  • Be followed from early pregnancy until 8 weeks postpartum

All participants (including control group) will:

  • Record body weight regularly throughout pregnancy using a telemedicine system
  • Complete questionnaires on dietary intake and quality of life at multiple time points
  • Undergo assessments of body composition and urinary biomarkers of oxidative stress during pregnancy

Study Overview

Detailed Description

This study is based on the hypothesis that dietary behavior during pregnancy plays a key role in determining maternal metabolic adaptation and pregnancy outcomes, particularly through its influence on gestational weight gain regulation and oxidative stress balance.

Pregnancy is characterized by physiological metabolic and endocrine adaptations that increase susceptibility to both under- and over-nutrition. Inadequate dietary patterns may contribute to excessive gestational weight gain, which has been associated with increased risk of maternal and neonatal complications. Conversely, nutritional imbalance may also affect fetal development and long-term health trajectories. Despite existing recommendations for healthy eating during pregnancy, adherence in real-world settings remains suboptimal, suggesting the need for structured behavioral interventions.

In addition to metabolic effects, pregnancy is associated with a physiological increase in oxidative stress, which is involved in placental development and fetal growth regulation. However, excessive oxidative stress has been linked to adverse outcomes including impaired placental function and increased risk of metabolic and hypertensive disorders. Dietary patterns rich in antioxidants, such as those emphasizing high-quality nutrients and balanced macronutrient intake, may contribute to modulating oxidative stress pathways.

The intervention tested in this study is grounded in behavioral nutrition and health education principles, with the aim of improving dietary awareness, food selection skills, and long-term adherence to nutritional recommendations. The group-based format is designed to enhance engagement, facilitate peer interaction, and improve cost-effectiveness compared to individual counseling approaches.

The study employs a randomized controlled design to minimize selection bias and allow causal inference regarding the effect of the intervention. Stratified randomization is used to ensure balance across clinically relevant prognostic factors, including pre-pregnancy BMI and parity, which are known to influence gestational weight gain and pregnancy outcomes.

The longitudinal structure of the study allows evaluation of both short-term behavioral changes during pregnancy and medium-term maternal outcomes extending into the postpartum period. The integration of behavioral, anthropometric, and biochemical assessments enables a multidimensional evaluation of the intervention's impact.

Study Type

Interventional

Enrollment (Actual)

216

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • CN
      • Verduno, CN, Italy, 12060
        • SC Nutrizione Clinica e Disturbi del Comportamento Alimentare ASL CN2, Italy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Pregnant women with gestational age ≤ 17 weeks at enrollment
  • Age ≥ 18 years
  • Ability to provide written informed consent
  • Availability of a personal smartphone for study participation and data reporting
  • Availability of a personal weight scale for home monitoring

Exclusion Criteria:

  • Multiple pregnancy
  • Pre-existing hypertension
  • Pre-existing diabetes mellitus
  • Pre-pregnancy body mass index (BMI) < 18.5 kg/m²
  • Pre-pregnancy body mass index (BMI) ≥ 35 kg/m²
  • History of psychiatric disorders
  • Overt hypothyroidism or hyperthyroidism
  • Celiac disease
  • Inflammatory bowel disease (ulcerative colitis or Crohn's disease)
  • History of bariatric surgery
  • Language barrier preventing comprehension of study procedures or completion of assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Structured Nutritional Education Intervention
Participants receive a structured group-based nutritional education program delivered during pregnancy by trained healthcare professionals. The intervention includes group educational sessions focused on healthy dietary patterns during pregnancy, nutrient requirements, meal planning, and gestational weight management, plus one practical cooking (show-cooking) session. Participants are followed longitudinally through pregnancy and postpartum and complete the same study assessments as the control arm.
Participants receive a structured group-based nutritional education program delivered during pregnancy by trained healthcare professionals. The program includes three weekly group educational sessions and one practical cooking (show-cooking) session. The intervention focuses on improving knowledge and practical skills related to healthy dietary patterns during pregnancy, nutrient intake, and gestational weight management.
Active Comparator: Routine Care + Brochure
Participants receive routine prenatal care according to standard clinical practice. In addition, they are provided with a written nutritional information brochure containing general dietary recommendations for pregnancy. This arm serves as the control condition for comparison with the structured nutritional education intervention. Participants are followed longitudinally through pregnancy and postpartum and complete the same study assessments as the intervention arm.
Participants receive routine prenatal care according to standard clinical practice. In addition, they are provided with a written nutritional information brochure containing general dietary recommendations for pregnancy. No structured educational sessions or group-based interventions are delivered in this arm.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of Participants Achieving Gestational Weight Gain Within Institute of Medicine (IOM) Recommended Ranges
Time Frame: From enrollment (12-17 weeks of gestation) to delivery.
This outcome assesses the proportion of participants whose total gestational weight gain falls within the Institute of Medicine (IOM) recommended ranges according to pre-pregnancy body mass index (BMI) categories. Pre-pregnancy BMI is used to classify recommended weight gain ranges, and total gestational weight gain is evaluated at the end of pregnancy.
From enrollment (12-17 weeks of gestation) to delivery.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Urinary Oxidative Stress Biomarkers During Pregnancy
Time Frame: From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
This outcome evaluates changes in oxidative stress status during pregnancy by measuring urinary levels of isoprostanes and malondialdehyde, as well as total antioxidant capacity, using validated laboratory assays.
From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
Change in Dietary Intake During Pregnancy
Time Frame: From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
This outcome assesses changes in dietary intake, including energy intake and macronutrient distribution (carbohydrates, proteins, fats including saturated and unsaturated fatty acids, and dietary fiber), measured using a validated food frequency questionnaire.
From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
Change in Maternal Quality of Life During Pregnancy
Time Frame: From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
This outcome evaluates changes in maternal quality of life using the WHOQOL-BREF questionnaire and the number of self-reported healthy days.
From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
Change in Maternal Body Composition During Pregnancy
Time Frame: From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
This outcome measures changes in maternal body composition assessed by bioelectrical impedance analysis.
From enrollment (12-17 weeks of gestation) to 30-35 weeks of gestation.
Gestational Weight Gain Rate Within Institute of Medicine Recommendations
Time Frame: From enrollment (12-17 weeks of gestation) to delivery.
This outcome evaluates the weekly rate of gestational weight gain according to Institute of Medicine (IOM) recommendations based on pre-pregnancy BMI.
From enrollment (12-17 weeks of gestation) to delivery.
Incidence of Maternal Pregnancy Complications
Time Frame: From enrollment (12-17 weeks of gestation) to delivery.
This outcome assesses the incidence of gestational diabetes mellitus, hypertensive disorders of pregnancy (including preeclampsia/eclampsia), and preterm birth.
From enrollment (12-17 weeks of gestation) to delivery.
Incidence of Neonatal Complications
Time Frame: At delivery.
This outcome evaluates neonatal outcomes including macrosomia and small-for-gestational-age infants.
At delivery.
Postpartum Maternal Weight Change
Time Frame: From delivery to 8 weeks postpartum.
This outcome assesses maternal weight change at 8 weeks postpartum compared with pre-pregnancy weight.
From delivery to 8 weeks postpartum.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Cloè Dalla Costa, SC Nutrizione Clinica e Disturbi del Comportamento Alimentare, Ospedale Michele e Pietro Ferrero, ASL CN2, Verduno (CN), Italy

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2023

Primary Completion (Estimated)

April 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

April 20, 2026

First Submitted That Met QC Criteria

April 20, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 24, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pregnancy

Clinical Trials on Structured Nutritional Education Program

Subscribe